These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
167 related articles for article (PubMed ID: 18813273)
1. Survival from bladder cancer in England and Wales up to 2001. Whelan P Br J Cancer; 2008 Sep; 99 Suppl 1(Suppl 1):S90-2. PubMed ID: 18813273 [No Abstract] [Full Text] [Related]
2. Survival from bladder cancer in England and Wales up to 2001. Shah A; Rachet B; Mitry E; Cooper N; Brown CM; Coleman MP Br J Cancer; 2008 Sep; 99 Suppl 1(Suppl 1):S86-9. PubMed ID: 18813272 [No Abstract] [Full Text] [Related]
3. Survival from breast cancer in England and Wales up to 2001. Leary A; Smith IE Br J Cancer; 2008 Sep; 99 Suppl 1(Suppl 1):S56-8. PubMed ID: 18813261 [No Abstract] [Full Text] [Related]
4. Survival from kidney cancer in England and Wales up to 2001. Hancock BW Br J Cancer; 2008 Sep; 99 Suppl 1(Suppl 1):S96-7. PubMed ID: 18813275 [No Abstract] [Full Text] [Related]
5. Survival from endometrial cancer in England and Wales up to 2001. Kitchener HC Br J Cancer; 2008 Sep; 99 Suppl 1(Suppl 1):S68-9. PubMed ID: 18813265 [No Abstract] [Full Text] [Related]
7. Survival from cancer of the uterine cervix in England and Wales up to 2001. Kitchener HC Br J Cancer; 2008 Sep; 99 Suppl 1(Suppl 1):S63-4. PubMed ID: 18813263 [No Abstract] [Full Text] [Related]
8. A case of T2 muscle-invasive bladder cancer treated with neoadjuvant chemotherapy. Gilbert SM; Lee CT Nat Clin Pract Urol; 2006 Dec; 3(12):675-9. PubMed ID: 17149384 [TBL] [Abstract][Full Text] [Related]
10. Validation of the AJCC TNM substaging of pT2 bladder cancer: deep muscle invasion is associated with significantly worse outcome. Tilki D; Reich O; Karakiewicz PI; Novara G; Kassouf W; Ergün S; Fradet Y; Ficarra V; Sonpavde G; Stief CG; Skinner E; Svatek RS; Lotan Y; Sagalowsky AI; Shariat SF Eur Urol; 2010 Jul; 58(1):112-7. PubMed ID: 20097469 [TBL] [Abstract][Full Text] [Related]
11. Survival from cancer of the lung in England and Wales up to 2001. Rachet B; Quinn MJ; Cooper N; Coleman MP Br J Cancer; 2008 Sep; 99 Suppl 1(Suppl 1):S40-2. PubMed ID: 18813256 [No Abstract] [Full Text] [Related]
12. The case for neoadjuvant chemotherapy and cystectomy for muscle invasive bladder cancer. deVere White RW; Katz MH; Steinberg GD J Urol; 2009 May; 181(5):1994-7. PubMed ID: 19286209 [No Abstract] [Full Text] [Related]
13. Survival from cancer of the uterus in England and Wales up to 2001. Cooper N; Quinn MJ; Rachet B; Mitry E; Coleman MP Br J Cancer; 2008 Sep; 99 Suppl 1(Suppl 1):S65-7. PubMed ID: 18813264 [No Abstract] [Full Text] [Related]
14. New strategies in muscle-invasive bladder cancer: on the road to personalized medicine. Shah JB; McConkey DJ; Dinney CP Clin Cancer Res; 2011 May; 17(9):2608-12. PubMed ID: 21415213 [TBL] [Abstract][Full Text] [Related]
15. Editorial Comment to Cancer death from non-muscle invasive bladder cancer: Report of the Japanese Urological Association of data from the 1999-2001 registry in Japan. Koga F Int J Urol; 2010 Nov; 17(11):913. PubMed ID: 20969638 [No Abstract] [Full Text] [Related]
16. The results of treatment of 107 patients with carcinoma of the bladder. Donker PJ Arch Chir Neerl; 1967; 19(3):179-85. PubMed ID: 5212320 [No Abstract] [Full Text] [Related]
17. Prognostic factors for survival in patients with recurrence of muscle invasive bladder cancer after treatment with curative intent. Ploeg M; Kums AC; Aben KK; van Lin EN; Smits G; Vergunst H; Viddeleer AC; Geboers AD; van Berkel H; van Boven E; Kiemeney LA; Witjes F Clin Genitourin Cancer; 2011 Sep; 9(1):14-21. PubMed ID: 21723794 [TBL] [Abstract][Full Text] [Related]
18. Small cell carcinoma of the urinary bladder. A clinicopathologic analysis of 64 patients. Montie JE J Urol; 2005 Jun; 173(6):1920-1. PubMed ID: 15879778 [No Abstract] [Full Text] [Related]
19. Survival after treatment for carcinoma invading bladder muscle: a Dutch population-based study on the impact of hospital volume. Goossens-Laan CA; Visser O; Hulshof MC; Wouters MW; Bosch JL; Coebergh JW; Kil PJ BJU Int; 2012 Jul; 110(2):226-32. PubMed ID: 22044615 [TBL] [Abstract][Full Text] [Related]
20. Editorial comment on: Protein expression patterns of ezrin are predictors of progression in T1G3 bladder tumours treated with nonmaintenance bacillus Calmette-Guérin. Gofrit ON Eur Urol; 2009 Nov; 56(5):836. PubMed ID: 18926619 [No Abstract] [Full Text] [Related] [Next] [New Search]